Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to find out if a different type of imaging study called
contrast enhanced ultrasound (CEUS) is as good as, or better than CT or MRI in patients
diagnosed with hepatocellular carcinoma (HCC) after receiving TACE treatment